Revolutionary new HIV drugs are being made available in 120 low-income countries, but many important populations are being left out. Sophie Cousins reports.

ACTG is honored to share these important findings with the many global stakeholders who are gathered in Indonesia at the Union Conference,” said ACTG Chair Judith Currier, M.D., M.Sc., University of ...

The federal government yesterday formally announced the commencement of the HIV Vaccine Innovation, Science, and Technology ...

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

HIV is an infection that can be transmitted from one person to another through sexual activity, such as anal, oral, or vaginal sex. The terms “sexually transmitted infections (STIs)” and ...

Early symptoms of mono and acute HIV infection include body aches, fatigue, fever, headaches, sore throat, and swollen lymph ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Oct. 31, 2024 — A research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an ... Kidney Transplantation ...

No writing assistance was utilized in the production of this manuscript. Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting ...